CareDx, Inc. (CDNA)
Tests organ transplant patients' blood to detect rejection before symptoms appear.
$36.08-0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+195.3%
The outlook
CareDx trades at $36.08 with analyst consensus leaning toward Buy across light coverage. The stock sits well above its key moving averages and trades near the upper end of its 52-week range. The average analyst price target sits roughly 2% below the current price.
What’s behind the score
Analyst consensusBuy — 2.1 avg of 5 analysts
Price trendAbove its 50- & 200-day averages
52-week range85% of the way from its 52-week low to high
Price targetAvg target -2% vs current price
Analyst price target
~12-month · 5 analysts$35.40average target-1.9% vs now
Now $36.08
Low $21.00High $50.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.86B
52-wk high
$40.47
52-wk low
$11.26
50-day avg
$26.91
200-day avg
$20.48
Trailing P/E
—